Additionally, cathepsin B (Cath B) is correlated with therapy resistance [25], and overexpression of this protease is associated with invasive phenotypes of many cancers [26]; moreover, this protein has been demonstrated to have a tumor-protective role [27]. Here, CTSB is linked to neoplasm.